![Quiver Logo](/static/img/logo-icon.png)
![ARDX logo](https://quiver-logos.s3.us-east-2.amazonaws.com/ardx.png)
Ardelyx, Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ARDX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of ARDX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ARDX's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to ARDX
Recent picks made for ARDX stock on CNBC
ETFs with the largest estimated holdings in ARDX
Flights by private jets registered to ARDX
![Quiver Logo](/static/img/logo-icon.png)